Ausnutria Dairy Reports H1 Loss as Revenue Falls

Ausnutria Dairy Corporation reported an 18.6% year-on-year decline in consolidated revenue for the six months ended in the first half of 2026. The specialised goat-milk and infant-formula manufacturer also recorded a net loss attributable to equity holders, reversing the profit reported for the same period a year earlier.

Management linked part of the revenue decline to operational and distribution measures introduced during the reporting period. The company adjusted commercial inventory levels and reorganised wholesale routes to market. Ausnutria said the changes caused a short-term interruption to sales volumes among important regional accounts.

The company also identified demographic conditions in China as an external factor affecting demand. Annual births in the country have fallen below eight million, reducing the domestic population of potential infant-formula consumers. The smaller market has increased competition for prices and retail shelf space among Chinese and international formula brands.

Ausnutria’s Kabrita goat-milk nutrition brand experienced lower sales volumes in China during the first half. The company attributed the decline to temporary shortages affecting some formulations and to planned dealer inventory adjustments. Those adjustments accompanied a restructuring of distribution agreements intended to improve product sell-through in retail channels.

Ausnutria did not provide specific financial guidance for the remaining operating quarters or for the full financial year. The company said it would respond to the contraction in China’s infant market by broadening its product range into functional adult nutrition and expanding its medical-food business.

The group also plans to extend Kabrita’s presence in overseas markets. The areas identified by the company include emerging markets in Southeast Asia, the Middle East and North America.